<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the relationship between plasma platelet-activating factor acetylhydrolase (PAF-AH) gene 994(G--&gt; T) mutation in exon 9 and the patients with <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> in Chinese Hans </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The authors conducted a case-control study including 108 patients in three groups (atherosclerotic <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> group, <z:e sem="disease" ids="C0333559" disease_type="Disease or Syndrome" abbrv="">lacunar infarction</z:e> group and <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> group) and 215 <z:mpath ids='MPATH_458'>normal</z:mpath> subjects as controls </plain></SENT>
<SENT sid="2" pm="."><plain>Genomic DNA was analyzed for the mutant allele by a specific polymerase chain reaction </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: The frequency of the mutant genotype in the 102 patients with <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> was 35.19%(32.41% heterozygotes and 2.78% homozygotes), and was 38.10%(34.92% heterozygotes and 3.18% homozygotes) in the atherosclerotic <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> group, being <z:hpo ids='HP_0000001'>all</z:hpo> significantly higher than the control group's 20.46% (18.60% heterozygotes and 1.86% homozygotes)(P&lt; 0.01); however, the frequencies of the mutant genotype in the <z:e sem="disease" ids="C0333559" disease_type="Disease or Syndrome" abbrv="">lacunar infarction</z:e> group and <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> group were 32.35% (29.41% heterozygotes and 2.94% homozygotes) and 27.27% (27.27% heterozygotes and 0 homozygotes) respectively, being not statistically different from those of the controls (P&gt; 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSION: These findings show that the 994(G--&gt; T) mutation of plasma PAF-AH gene may be an independent risk for atherosclerotic <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e>, but not for <z:e sem="disease" ids="C0333559" disease_type="Disease or Syndrome" abbrv="">lacunar infarction</z:e> </plain></SENT>
</text></document>